BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35536326)

  • 21. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
    Wu YW; Tan CH
    Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index.
    Miyake H; Takaki H; Matsumoto S; Yoshida S; Maeda T; Mori H
    Abdom Imaging; 1995; 20(6):559-62. PubMed ID: 8580753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
    Patel J; Davenport MS; Cohan RH; Caoili EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep learning approach for differentiating indeterminate adrenal masses using CT imaging.
    Singh Y; Kelm ZS; Faghani S; Erickson D; Yalon T; Bancos I; Erickson BJ
    Abdom Radiol (NY); 2023 Oct; 48(10):3189-3194. PubMed ID: 37369921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
    Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
    AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differential diagnosis of space-occupying adrenal masses].
    Szolar DH; Unger B; Heinz-Peer G; Preidler K; Ranner G
    Rofo; 1999 Oct; 171(4):269-78. PubMed ID: 10598161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
    Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
    Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
    Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
    Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
    Warda MH; Shehata SM; Zaiton F
    Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CT and MRI in the differential diagnosis of lesions of the adrenal gland].
    Ghanem N; Altehoefer C; Thürl C; Bley T; Langer M
    Med Klin (Munich); 2004 Aug; 99(8):447-52. PubMed ID: 15309273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
    Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
    Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are the washout values currently accepted for lesion characterization in dedicated adrenal CT adequate for diagnosis?
    Gündoğdu E; Oğuzman M; Emekli E; Kebapçı M
    Diagn Interv Radiol; 2021 Nov; 27(6):694-702. PubMed ID: 34792022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
    Jhaveri KS; Wong F; Ghai S; Haider MA
    AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
    Porte HL; Ernst OJ; Delebecq T; Métois D; Lemaitre LG; Wurtz AJ
    Eur J Cardiothorac Surg; 1999 May; 15(5):597-601. PubMed ID: 10386403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT and MR distinction of adenomas and nonadenomas of the adrenal gland.
    van Erkel AR; van Gils AP; Lequin M; Kruitwagen C; Bloem JL; Falke TH
    J Comput Assist Tomogr; 1994; 18(3):432-8. PubMed ID: 8188912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT of hemorrhagic adrenal adenomas: radiologic-pathologic correlation.
    Corwin MT; Kadivar SC; Graves CE; Kamangar E; Carney BW; Campbell MJ
    Abdom Radiol (NY); 2023 Feb; 48(2):680-687. PubMed ID: 36380211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal masses: CT characterization with histogram analysis method.
    Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
    Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: can biopsy be obviated?
    Slapa RZ; Jakubowski W; Januszewicz A; Kasperlik-Zaluska AA; Dabrowska E; Fijuth J; Feltynowski T; Tarnawski R; Królicki L
    Eur Radiol; 2000; 10(1):95-104. PubMed ID: 10663723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.